News

Latest

The AHA’s Association for Health Care Resource & Materials Management has elected Dee Donatelli, acting principal at Dee Donatelli Consulting LLC, as the 2019 AHRMM Board chair-elect.
A nationally-recognized leader in hospital/physician relations and clinical integration, Nicholas Wolter, M.D., former CEO of Billings Clinic in Billings, Mont., died Sept. 7.
The AHA today voiced support for a Federal Communications Commission proposal to create a $100 million pilot program to support telehealth for low-income Americans.
Hospitals participating in the first year of Medicare’s Comprehensive Care for Joint Replacement Model reduced payments for lower extremity joint replacement episodes by an average 3.3 percent more than hospitals that did not participate in the model.
The Food and Drug Administration Friday approved a new dosage option for buprenorphine and naloxone sublingual film, applied under the tongue as a maintenance treatment for opioid dependence.
Employment at the nation's hospitals rose by 0.16% in August to a seasonally adjusted 5,189,300 people, the Bureau of Labor Statistics reported Friday.
by Nancy Agee
The AHA is opening a new chapter in advancing health in America.
The Senate is expected to vote next week on the Opioid Crisis Response Act of 2018, a substitute amendment to the House-passed opioid package (H.R. 6).
The AHA appreciates the steps the Centers for Medicare & Medicaid Services is taking to streamline the Quality Payment Program and reduce burden for clinicians, but “is very concerned about the collapse of payment rates for evaluation and management visit codes.”
The House Energy and Commerce Health Subcommittee today approved legislation that would prohibit Medicare and private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.
The Food and Drug Administration today released for public comment a revised draft memorandum of understanding for states regarding interstate distribution of “inordinate amounts” of compounded drugs by licensed pharmacists or physicians.
The AHA and Center to Advance Palliative Care this week announced a strategic partnership to develop and disseminate training and other resources to help health care providers expand access to palliative care and adopt a population health approach to improve care for patients with serious illness.
The Alliance for Recovery-Centered Addiction Health Services, of which the AHA is a member, today announced an alternative payment model designed to provide patients a long-term, comprehensive and integrated pathway to addiction treatment and recovery.
As part of the AHA’s Hospitals Against Violence initiative, the American Organization of Nurse Executives will host a webinar Sept. 12 at 12 p.m. ET exploring the issue of human trafficking from the perspective of a mother of a survivor.
The AHA’s Association for Community Health Improvement is accepting proposals through Sept. 28 for breakout sessions and posters to be presented at its 2019 National Conference, March 19-21 in Chicago.
by Rick Pollack
There is a lot of focus today on health care costs, and what can be done to contain them. One sure-fire strategy? Reduce the regulatory burden that is drowning providers in red tape and adding costs to the system.
The House Ways and Means Committee yesterday approved legislation that would establish a three-year pilot program to test using smart card technology to combat Medicare fraud and protect beneficiary identity.
The federal government violated a statutory obligation created by Congress in the Affordable Care Act when it failed to provide Montana Health, an issuer of qualified health plans on the Montana and Idaho health insurance exchanges, its full cost-sharing reduction payments for 2017, a federal judge ruled yesterday.
More than 150 nurse leaders yesterday attended an American Organization of Nurse Executives’ Advocacy Day in Washington D.C.
Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications.